Consonance Capital Management LP - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 65 filers reported holding UROGEN PHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Consonance Capital Management LP ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q2 2019$51,530,000
-20.7%
1,433,774
-18.5%
3.65%
-11.1%
Q1 2019$64,989,000
-0.4%
1,759,324
+16.1%
4.10%
-14.5%
Q4 2018$65,254,000
-8.8%
1,515,4220.0%4.80%
+24.5%
Q3 2018$71,573,000
-3.3%
1,515,422
+1.9%
3.85%
-19.3%
Q2 2018$74,018,000
+30.0%
1,487,491
+29.8%
4.77%
-8.3%
Q1 2018$56,955,000
+67.0%
1,146,197
+25.1%
5.20%
+69.0%
Q4 2017$34,101,000916,4503.08%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders